SV2A and Alzheimer disease: Between‐group analyses indicated that CSF SV2A was significantly lower in the AD group, compared to either the CU Aβ+ group (unpaired t‐test, p < 0.0001) or the CU Aβ‐ group (unpaired t‐test, p < 0.0001).